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INTRODUCTION 
Pustular psoriasis is a rather uncommon form of 
psoriasis in Malaysia, representing less than 1.6% of 
psoriasis cases [1]. We report a case of pustular 
psoriasis as a first presentation of severe psoriasis, in a 
young school boy complicated with arthritis and liver 
impairment. Delay in inducing pustular remission was 
due to the difficulties in initiating systemic treatment in 
the presence of acute hepatitis. 
 
CASE PRESENTATION 
A 13-year-old boy presented with generalised 
erythematous skin lesions involving 90% of his body 
surface area and appearance of pustules over past one 
week. One month prior to the current illness he had 
developed small scaly plaques on his scalp and legs. He 
gave a history of receiving oral diclofenac for a sports 
injury one week prior to the development of scaly 
plaques. During the course of the development of scaly 
lesions, he was treated with oral erythromycin for upper 
respiratory tract infection and the skin lesions became 
diffusely erythematous and studded with pustules two 
weeks later. The lesions were itchy and painful. They 
were associated with intermittent fever, myalgia, 
conjunctivitis and joint pain over his hips, right knee, 
left ankle and lower back. Of note, his mother has 
systemic lupus erythematosus and is on treatment. He 
had no family history of psoriasis or atopy. 
On examination, his temperature was 37.8°C, 
blood pressure was 130/80 mmHg, heart rate was 110 
beats per minute and Spo2 was 100%. There was 
generalized erythema on the face, limbs and trunk 
(Figure 1). Thick scaly plaques covered almost the 
entire scalp. Skin was generally erythematous with total 
body surface area involvement up to 90%. There were 
pustules studded on the erythematous patches on his 
trunk and limbs, with areas of desquamation. There 
were thick scales on his soles (Figure 2). His nails 
showed onycholysis, pitting and subungual 
hyperkeratosis (Figures 3). He had swelling and 
tenderness over his left ankle. Cardiovascular, 
respiratory, abdominal examinations were normal. 
 
ABSTRACT 
 
We report a case of a 13-year-old boy who presented with acute onset of generalised 
erythematous skin and patchy areas of pustules for one week duration. He was well until one 
month ago when he started having small scaly plaques on his scalp and extensors of his legs. 
During the acute episode, he also had joint pain and bilateral conjunctivitis. Skin biopsy 
confirmed pustular psoriasis. He developed leucocytosis and transaminitis during the acute 
phase of the pustular eruption while on acitretin, which was then withheld. Subsequently, 
treatment with oral cyclosporine induced remission of his skin and joint disease. The case is 
hereby reported because of rarity of presentation and clinical features. Oral cyclosporine should 
be considered in patients with generalised pustular psoriasis complicated with transaminitis. 
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Figure 1 Pustules on erythematous base on the trunk 
 
 
 
 
Figure 2 Thickened hyperkeratotic soles 
 
 
 
Figure 3 Clinical findings on both feet. a) Pustules on the dorsum of feet b) 
Subungual hyperkeratosis c) Onycholysis 
 
Baseline blood investigation showed 
hemoglobin 12.6 g/dL, platelet count 208 X 109/L, total 
white count 10.32 X 109/L, alanine transaminase (ALT) 
45 U/L, aspartate transaminase (AST) 30 U/L, 
rheumatoid factor negative, normal renal profile, 
corrected serum calcium 2.25 mmol/L, ASOT negative, 
erythrocyte sedimentation rate 20 and C-reactive 
protein (CRP) of 3.88. His viral screen was negative. 
ANA and rheumatoid factor were negative. Pelvic 
radiograph showed left sacroillitis. Chest radiograph 
was clear. Skin biopsy done 16 days after admission 
showed parakeratosis, mild acanthosis with elongation 
and thickening of the rete ridges. There was scattered 
spongiosis with early pustule formation (spongiform 
pustule of Kogoj). The papillary dermis was 
oedematous with mild infiltrate of lymphocytes and 
some neutrophils around the superficial dermal blood 
vessels. These results were compatible with the clinical 
diagnosis of pustular psoriasis. 
Treatment proved to be challenging and 
systemic steroid was started for arthritis and was 
tapered down after introduction of steroid sparing 
agents. This patient was started on acitretin and 
continued a prednisone taper. Liver enzymes became 
elevated by the fifth day of acitretin therapy. Peak liver 
enzyme values on day 6 were 368 U/L and 97 U/L for 
ALT and AST respectively. Elevated liver enzyme 
levels were accompanied with a rise in CRP to 14. 
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However, the patient did not develop any symptoms of 
hepatotoxicity. Acitretin was discontinued and liver 
enzyme levels returned to baseline within 1 week. At 
this time, ultrasound of the hepatobiliary system and 
screening for autoimmune hepatitis was done and was 
negative. Oral methotrexate was not an option at this 
point of time for the same reason. He was started on oral 
cyclosporine 50 mg twice a day. The pustules had 
remitted after 48 - 96 hours of starting cyclosporine. 
Three weeks later, the transaminases were restored to 
normal values and his general clinical condition 
improved. The high dose of systemic steroids could be 
tapered down without recurrent pustular flare and the 
joints pain dramatically resolved. His disease remained 
stable throughout the outpatient follow up in the first 
year, but had recurrent flares of generalised pustular 
psoriasis subsequently in the following 4 years. 
Currently, patient is awaiting biologics treatment. 
 
DISCUSSION 
Generalized pustular psoriasis (GPP) is a serious 
dermatological disease characterized by fever, chills, 
rigors, and generalized pustule formation on the skin [2, 
3]. The occurrence of GPP in childhood is rare, and 
fewer than 200 cases have been reported in the literature 
[4]. Several antigenic factors have been shown to elicit 
GPP, including withdrawal of steroids, emotional 
stress, infection, drugs such as lithium and 
hydrochloroquine, irritative topical therapy (e.g. coal 
tar), dental and upper respiratory infections, pregnancy, 
and solar irradiation [4, 5]. Recessive mutations of 
IL36RN have been identified in majority of GPP 
patients, without previous history of psoriasis [6]. 
Furthermore, studies done in Japan have shown that the 
age of onset of the pustular outbreak in psoriasis naïve 
patients is earlier and occurs more frequently following 
infections [3]. 
This was a case of pustular psoriasis in a young 
boy who presented with erythroderma which is a rare 
presentation of pustular psoriasis. The occurrence of 
mucosal involvement is also rare and was found in this 
patient who had sterile conjunctivitis [7]. The 
commoner presentation of pustular psoriasis in 
Malaysia are fever, painful skin, arthritis and 
leucocytosis [8]. 
Possible differential diagnoses include acute 
generalized exanthematous pustulosis, Gram negative 
sepsis, subcorneal pustular dermatosis and Ofuji 
syndrome. Clinical presentation and the histopathology 
confirmed the diagnosis of pustular psoriasis. GPP is an 
acute form that presents itself by sudden eruption of 
sterile papules on erythematous base and is 
accompanied by severe systemic symptoms and is also 
known as von Zumbusch. 
Notably, this patient also had elevated liver 
enzymes during the acute phase of the disease which 
subsequently subsided as his condition improved. 
Studies have shown that the occurrence of liver enzyme 
abnormalities in patients with GPP was 47% with an 
increased leucocyte count and male preponderance [8].  
With regards to the treatment options, there is 
little evidence based information to guide the treatment 
of GPP. Acitretin, cyclosporine, methotrexate, and 
infliximab are considered to be first-line therapies [9]. 
Adalimumab, etanercept, and psoralen plus ultraviolet 
A are second-line modalities [9]. Studies have also 
shown that acitretin appears to provide better efficacy 
in pustular psoriasis than in psoriasis vulgaris as 
monotherapy [10]. There are also reports of successful 
use of dapsone in the treatment of GPP [11]. 
As the patient continued to have  flares of 
pustules and a painful hip joint with transaminitis, 
which persisted despite discontinuing acitretin, the 
decision to start an alternative immunosuppressive drug 
proved to be a challenging one. Studies done in children 
with pustular psoriasis have shown that cyclosporine is 
effective and safe for children with a median time to 
total clearance of 4 weeks [12]. There have also been 
reports of successful use of cyclosporine in pregnancy 
with good outcome [13]. The recommended starting 
dose of 5 mg/kg is associated with a higher degree of 
clearance in patients with GPP [14]. In this case, oral 
cyclosporine induced remission of both the skin and 
joint disease. 
The nature of the swollen joint, whether 
psoriatic or reactive was not well defined in this case 
from clinical appearance alone. Features favouring the 
diagnosis of reactive arthritis were younger age of 
onset, sacroillitis and keratoderma of the soles [15]. 
This differentiation was important to predict long term 
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prognosis for this patient as psoriatic arthritis is 
associated with higher morbidity. 
In conclusion, the management of patients with 
pustular psoriasis generally requires systemic agents 
such as acitretin, methotrexate, cyclosporine and 
azathioprine. All of these require special precautions. In 
managing this patient, the choice of systemic agent 
proved to be a challenge. Although there are guidelines 
in managing acute pustular psoriasis, the management 
decision should be individually tailored according to the 
clinical scenario. 
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